RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
This Quarter Return
+11.71%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$722M
AUM Growth
+$722M
(-7.7%)
Cap. Flow
-$98.1M
Cap. Flow
% of AUM
-13.59%
Top 10 Holdings %
Top 10 Hldgs %
77.92%
Holding
44
New
2
Increased
3
Reduced
9
Closed
12
Top Buys
1 |
Ascendis Pharma
ASND
|
$16.6M |
2 |
Spyre Therapeutics
SYRE
|
$2.54M |
3 |
Merus
MRUS
|
$1.9M |
4 |
Nektar Therapeutics
NKTR
|
$655K |
5 |
Ardelyx
ARDX
|
$103K |
Top Sells
Sector Composition
1 | Healthcare | 93.56% |